Hypogonadism: understanding primary and secondary forms
A low testosterone value is only the start of a question, not the answer. What matters is where the disturbance sits: in the testes themselves or in the control from hypothalamus and pituitary. The pattern of LH and FSH becomes the map. Read it, and you understand hypogonadism not as one finding, but as a family of conditions with different origins.
When a low testosterone value sits on a report, I often hear the question: "What do I do about it now?" I like to answer with a question of my own: "Do we already know where the problem sits?" Because hypogonadism is not one single damage. It can lie in the testes or in the control in the brain, it can be fixed and lasting or changeable. A low value alone says little about that. Only when we know the form does a number become a map. And a map shows not only where you stand, but also which paths exist.
Perhaps you are holding a lab report right now. Testosterone low, a small arrow pointing down behind it. Perhaps someone told you this was hypogonadism, and you wonder what that actually means. The term sounds like a clear diagnosis, but it is more of a headline. Beneath it hide very different stories.
In this article we look behind the headline. We clarify what hypogonadism actually is, why the question about the location of the disturbance changes everything, and how the pattern of LH and FSH becomes the map. We separate primary from secondary hypogonadism, the organic from the functional causes, and place what careful diagnostics can offer. By the end you will understand your finding not as a verdict, but as a starting point.
What hypogonadism actually means
Hypogonadism literally means that the gonads do too little. In men these are the testes. They have two tasks: they make testosterone, and they make sperm. In hypogonadism at least one of these tasks is disturbed, usually testosterone production, often both at once. The result in the blood is a low testosterone, frequently accompanied by symptoms such as lack of drive, declining libido or erection problems.
So much for the simple version. But the decisive point comes now. A low testosterone value is only an end result. It does not yet say where in the control chain something has stalled. Picture hormone production as a chain of command. At the very top sits the hypothalamus in the brain, which through a messenger called GnRH instructs the pituitary. The pituitary then sends LH and FSH into the blood, and these two finally reach the testes, which make testosterone and sperm. A disturbance can sit at any point in this chain.
A low testosterone value is not a diagnosis, it is an open question. The real diagnosis is not "too little testosterone", but "too little testosterone, because at this point in the chain something is catching". Only this placement tells you whether it is about the testes, the control in the brain, or a changeable phase of life. And that is exactly what changes what a treatment looks at first.
The central question: testes or pituitary?
When testosterone is low, there are two fundamentally different explanations. Either the testes themselves can no longer deliver enough, although the control calls loudly. Or the control in the brain is dampened and calls too quietly, so the testes are never asked to work at full capacity. These two scenarios carry names.
In primary hypogonadism the problem lies in the testes. It is also called hypergonadotropic hypogonadism, because the control hormones are high. The brain notices that too little testosterone arrives and turns up the volume. LH and FSH rise, yet the testes still cannot deliver. In secondary hypogonadism, by contrast, the problem lies in the control itself, in hypothalamus or pituitary. It is called hypogonadotropic hypogonadism, because the control hormones are low or inappropriately normal. The call for testosterone is quiet, so the testes work only on a low flame.
And this is exactly where the lab becomes a map. Because LH and FSH reveal in which direction to look.
LH separates primary, secondary and compensated hypogonadism
Cross-sectional, n=3369 Abdelouahid Tajar and colleagues analysed in 2010 in the Journal of Clinical Endocrinology and Metabolism the data of the European Male Ageing Study, with 3369 men aged 40 to 79 from eight European centres. They grouped the men by testosterone and LH: secondary (low testosterone, low or normal LH), primary (low testosterone, high LH) and compensated (normal testosterone, high LH). Secondary hypogonadism was closely linked to obesity, a body mass index of 30 or more raised the risk markedly. Primary hypogonadism, by contrast, was mainly linked to age. This suggests that the pattern of testosterone and LH can make different forms visible.
Tajar A, Forti G, O'Neill TW, et al. J Clin Endocrinol Metab. 2010;95(4):1810-1818. doi:10.1210/jc.2009-1796 · PMID: 20173018
And now you know why a good report never shows testosterone alone. Only LH and FSH alongside it turn a low value into a direction.
The four KPNI lenses on hypogonadism
In clinical psychoneuroimmunology, KPNI for short, we do not look at a single hormone value. We ask through which levels the control is influenced, right down to the cell. These four lenses explain why hypogonadism can have such different origins.
Nervous system and control
At the very top of the chain sits the hypothalamus, which releases GnRH in pulses. These pulses are the actual start signal. At the cell level, the cells of the pituitary respond only when the signal arrives in the right rhythm. Chronic stress, opioids or a disturbed GnRH control can dampen this rhythm. That produces a secondary hypogonadism, without anything being wrong with the testes themselves.
Immune system and inflammation
From belly fat stream inflammatory messengers that can dampen the control in the brain at the cell level. Severe general illness and acute inflammation also temporarily lower testosterone. The body then prioritises defence over reproduction. This inflammation-driven dampening is a core mechanism of functional hypogonadism and one reason why this state can be changeable.
Metabolism and aromatase
In fat tissue sits the enzyme aromatase, which converts testosterone into oestrogen. More belly fat means more conversion. At the cell level the shifting ratio of testosterone to oestrogen alters the feedback to the brain and can dampen the control further. On top of this, excess insulin promotes fat storage. So a loop arises that explains the secondary, functional hypogonadism in obesity.
Hormone system and testes
Here the chain ends, in the Leydig cells of the testes, which make testosterone in response to the LH signal. In primary hypogonadism these cells are damaged, for example by an extra chromosome, a past inflammation or radiation. At the cell level the workshop is simply missing. That is why LH rises in vain. To understand hypogonadism, you have to read these four levels as one connected system.
These four lenses are not an end in themselves. They explain why one form can improve and the other stays, and why the question about the location of the disturbance decides the whole path that follows.
Primary hypogonadism: when the testes are the problem
In primary hypogonadism the cause lies in the testis itself. The most common congenital cause is Klinefelter syndrome, in which an extra X chromosome is present. Those affected often have small, firm testes and limited sperm production. Acquired causes are past testicular inflammation such as after mumps, a testis that did not descend in childhood, injuries, surgery, and radiation or chemotherapy. Ageing belongs here too, because testicular function slowly declines over the years.
A common but often late-recognised cause
Review A review in Archives of Disease in Childhood summarises that Klinefelter syndrome, affecting about one in 600 male newborns, is the most common genetic cause of primary hypogonadism, but is frequently recognised late or not at all. Typical are small testes, reduced fertility and a raised LH with low testosterone. The authors stress that early placement can help in understanding puberty, bone health and metabolism. This suggests that the form behind a low value has concrete consequences for the further care.
Bonomi M, et al. Klinefelter syndrome: going beyond the diagnosis. Arch Dis Child. 2023;108(3):166-171. doi:10.1136/archdischild-2020-320831 · PMID: 35948402
The connecting feature of all primary forms: the control in the brain works, it even calls louder than usual. Yet the testes cannot follow the call. In the lab this shows as the typical pattern of low testosterone with high LH and often high FSH. These forms are usually lasting, because the damage lies in the tissue itself.
"Hypogonadism is always a sign of ageing." That is not quite right. While testicular function slowly declines over the years, and primary forms become more common with age, it is precisely the young man with low testosterone who deserves a close look. A Klinefelter syndrome, a congenital hypogonadotropic hypogonadism or a pituitary tumour have nothing to do with age. A low value in a 25-year-old deserves the same careful workup as in a 65-year-old, only with different likely causes.
Secondary hypogonadism: when the control goes quiet
In secondary hypogonadism the cause sits one floor higher, in hypothalamus or pituitary. The testes would be able to work, but they receive no adequate signal. Congenital forms affect the GnRH control from birth. Acquired causes include benign pituitary tumours, raised prolactin, certain medicines such as opioids or anabolic steroids, severe general illness and above all marked obesity.
A particular congenital form is congenital hypogonadotropic hypogonadism. When it goes together with a missing or limited sense of smell, it is called Kallmann syndrome.
When GnRH control is disturbed from birth
Consensus document Ulrich Boehm and colleagues described in 2015 in Nature Reviews Endocrinology, in a European consensus document, congenital hypogonadotropic hypogonadism. It arises through disturbed production or action of GnRH, the topmost control hormone of the reproductive axis. Clinically it often shows as an absent puberty and limited fertility. In about half of those affected the sense of smell is also involved, which is called Kallmann syndrome and goes back to a disturbed migration of the GnRH nerve cells during embryonic life. The authors stress that this form can be hard to tell apart from a delayed but normal puberty.
Boehm U, Bouloux PM, Dattani MT, et al. Nat Rev Endocrinol. 2015;11(9):547-564. doi:10.1038/nrendo.2015.112 · PMID: 26194704
The by far most common acquired cause of a secondary hypogonadism, however, is not rare but everyday: obesity. Here the control calls quietly, because inflammatory signals and the conversion of testosterone into oestrogen dampen the axis. The result is low testosterone with inappropriately normal LH.
Obesity dampens the control, not the testes
Review A review in the Journal of Clinical Endocrinology and Metabolism from 2025 describes how, in men with obesity, a low total testosterone with inappropriately normal LH frequently arises, that is, a secondary hypogonadism. Involved are a lowered binding protein SHBG, the conversion of testosterone into oestrogen in fat tissue, and inflammatory signals that dampen the control. The author places that many of these men do not have a classic organic hypogonadism, and that the state can improve through weight loss. This suggests that here the control is dampened and not the testes damaged.
Grossmann M. Approach to the Patient: Low Testosterone Concentrations in Men With Obesity. J Clin Endocrinol Metab. 2025. doi:10.1210/clinem/dgaf137 · PMID: 40052430
And now it becomes understandable why, with a secondary hypogonadism, the first question is often not about the testis, but about the control and what dampens it.
Functional or organic: the question that changes everything
There is a second dividing line that is just as important as primary versus secondary. It runs between organic and functional hypogonadism. In organic hypogonadism a fixed, structural disease is present, such as an extra chromosome, a loss of testes or a pituitary tumour. In functional hypogonadism, by contrast, no lasting damage is detectable, but a changeable state that dampens the control. Typical triggers are marked obesity, poorly controlled diabetes, severe co-existing illness, sleep loss and chronic stress.
The difference is not academic. It decides whether the state can improve. In functional hypogonadism the first lever often lies in the underlying state, not in the hormone.
A changeable form, not a fixed defect
Review A review in The Aging Male from 2024 places the term functional hypogonadism. What is meant is a low testosterone without detectable structural disease of the axis, often in the context of obesity, metabolic syndrome and co-existing illness. The authors stress that treating the underlying factors, above all weight, should come first, and that giving hormones is to be weighed more critically here than in organic forms. This suggests that placing it into functional or organic changes the order of the steps.
Dimou NL, et al. Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge. Aging Male. 2024;27(1):2296460. doi:10.1080/13685538.2023.2296460 · PMID: 38149634
How changeable a functional form can be is shown by a large Australian lifestyle study. It suggests that in men metabolism and the hormone system are closely connected.
Lifestyle and weight reach into the hormonal state
RCT, double-blind, n>1000 Gary Wittert and colleagues studied in 2021 in The Lancet Diabetes and Endocrinology, in the T4DM study over two years, more than a thousand men with obesity and prediabetes. All took part in a lifestyle programme, one half additionally received testosterone, the other a placebo. In the testosterone group markedly fewer men developed diabetes. At the same time the haematocrit rose in many, that is, the thickening of the blood, which can limit the treatment. The study shows how closely weight, metabolism and the hormonal state are connected in men, and that lifestyle is a real player here.
Wittert G, Bracken K, Robledo KP, et al. Lancet Diabetes Endocrinol. 2021;9(1):32-45. doi:10.1016/S2213-8587(20)30367-3 · PMID: 33338415
From a KPNI view this is a familiar thought. Functional hypogonadism is often the hormonal echo of a metabolic and inflammatory state. Whoever changes this state also changes the conditions for hormonal control. That is no guarantee, but a direction.
How careful diagnostics determine the form
For a low value to become a form, more than a single measurement is needed. A good workup starts with the symptoms and the physical examination and then relies on the lab in the right order. Guidelines such as those of the Endocrine Society give a clear framework here.
First measure reliably, then determine the form
Guideline Shalender Bhasin and colleagues formulated in 2018 in the Journal of Clinical Endocrinology and Metabolism the Endocrine Society guideline on testosterone therapy in hypogonadism. They recommend making the diagnosis only in men with clear symptoms and repeatedly low testosterone, measured in the morning and fasting on at least two days. To tell primary from secondary hypogonadism, LH and FSH should be determined. In secondary forms, further workup of the pituitary can make sense, such as prolactin and where appropriate imaging. This suggests that an ordered workup makes the form visible, rather than just delivering a number.
Bhasin S, Brito JP, Cunningham GR, et al. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229 · PMID: 29562364
One value deserves particular attention: free testosterone. Most testosterone in the blood is bound to the binding protein SHBG and is therefore not freely available. In some men the total testosterone is normal, but the free testosterone is low.
Free testosterone can make the difference
Cross-sectional, n=3334 Leen Antonio and colleagues analysed in 2016 in the Journal of Clinical Endocrinology and Metabolism the data of 3334 men from the European Male Ageing Study. They found that men with normal total testosterone but low free testosterone had more sexual and physical symptoms than men with both values normal. Conversely, in men with a low total value but normal free value the typical signs of deficiency were missing. The authors conclude that, when hypogonadism is suspected, free testosterone should be determined. This suggests that the total value alone can be misleading.
Antonio L, Wu FCW, O'Neill TW, et al. J Clin Endocrinol Metab. 2016;101(7):2647-2657. doi:10.1210/jc.2015-4106 · PMID: 26909800
How close the link between low testosterone and symptoms is was shown by a further analysis of the same large study, which contributed to the definition often used today.
Three sexual symptoms plus a low value
Cross-sectional, n=3369 Frederick Wu and colleagues searched in 2010 in the New England Journal of Medicine for criteria for late-onset hypogonadism. In the European Male Ageing Study it turned out that only three sexual symptoms had a clear link to low testosterone: weak morning erections, low desire and erection problems. From this they derived that this diagnosis needs the coming together of at least these three symptoms with a total testosterone below about 11 nanomoles per litre. This suggests that not every low value and not every fatigue already means a hypogonadism that needs treatment.
Wu FCW, Tajar A, Beynon JM, et al. N Engl J Med. 2010;363(2):123-135. doi:10.1056/NEJMoa0911101 · PMID: 20554979
Three levers that help with the placement
Before a treatment is discussed, it is worth looking at the foundations of a good placement. These three levers do not replace a medical workup. They help you understand your finding better and ask the right questions.
Ask for the full pattern, not just one number
A single testosterone value is rarely meaningful. What makes sense is a measurement in the morning and fasting, ideally repeated, together with LH and FSH. Only this pattern shows whether the disturbance sits more in the testes or in the control. Where suspected, free testosterone can help further. Whoever knows the whole picture understands their finding as a map and not as a mere label.
Ask for the form before you think about the treatment
Whether primary or secondary, whether organic or functional, that changes everything that follows. A functional form can improve when the underlying state is addressed. An organic form needs different care. This placement is not a detail but the actual core of the diagnosis. Knowing it protects against hasty steps in one direction or the other.
Look at what can dampen the control
Especially in secondary, functional hypogonadism it is worth looking at weight, sleep, stress, medicines and co-existing illness. Obesity is the most common state linked to it in men. A lasting change of these factors can improve the conditions for hormonal control. That is no guarantee, but a starting point that a good workup takes seriously, rather than skipping it.
And if the symptoms remain despite good foundations, a workup belongs to it that orders the whole picture. Testosterone replacement therapy is prescription-only and belongs in experienced medical hands, with clear placement of the form, regular monitoring and information about benefit and risk.
The value is not the diagnosis, the story behind it is
A low testosterone value is the start of a question. Only when you know where the disturbance sits and whether it is fixed or changeable does the number become a map. This map shows you not only where you stand, but also which paths are open. You do not have to read it alone. But you may know that it exists.
Frequently asked questions about hypogonadism
What is hypogonadism in simple terms?
Hypogonadism means that the testes make too little testosterone, often alongside impaired sperm production. The key question is where the cause sits. In primary hypogonadism the testes themselves are in trouble. In secondary hypogonadism the problem sits one floor higher, in the control from hypothalamus and pituitary in the brain. Both lead to low testosterone, but the path there differs, and so does the workup. Hypogonadism is therefore not a single finding but a family of conditions with different origins. Only placing it into a form turns a low value into a meaningful diagnosis.
What is the difference between primary and secondary hypogonadism?
The difference lies in the location of the disturbance. In primary hypogonadism the testes themselves are affected. The brain calls loudly for testosterone, yet the answer stays weak. In the blood this shows as low testosterone with high LH and often high FSH. In secondary hypogonadism the control in the brain is dampened. The call for testosterone is quiet, so LH and FSH are low or inappropriately normal while testosterone is also low. The pattern of these control hormones is therefore the key to telling the two forms apart. It reveals whether the problem sits in the workshop or in the control room.
What do LH and FSH mean in hypogonadism?
LH and FSH are messengers from the pituitary gland. LH triggers testosterone production in the testes, FSH supports sperm production. They work like a remote control for the testes. If the testes are weakened, the brain turns up the volume and LH and FSH rise. That points to primary hypogonadism. If instead the control itself is quiet, LH and FSH are low or inappropriately normal even though testosterone is low. That points to secondary hypogonadism. Reading testosterone, LH and FSH together can therefore often already place which level the disturbance sits on.
What causes primary hypogonadism?
In primary hypogonadism the cause lies in the testes. This includes Klinefelter syndrome with an extra X chromosome, past testicular inflammation such as after mumps, undescended testes in childhood, injuries, radiation or chemotherapy, and loss of testes through surgery. Ageing also plays a role, because testicular function slowly declines over the years. Data from the European Male Ageing Study suggest that primary forms become more common with rising age. What these causes share is that the testes can no longer deliver enough despite loud control from the brain.
What causes secondary hypogonadism?
In secondary hypogonadism the cause sits in the higher control from hypothalamus and pituitary. Congenital forms such as congenital hypogonadotropic hypogonadism or Kallmann syndrome affect the GnRH control from birth. Acquired causes include benign pituitary tumours, raised prolactin, certain medicines such as opioids or anabolic steroids, severe general illness and above all marked obesity. Obesity is the most common state linked to secondary hypogonadism in men. Here the control is dampened, not the testis defective, which is why telling functional and organic causes apart matters so much.
What does functional hypogonadism mean?
Functional hypogonadism describes a low testosterone value behind which there is no fixed structural disease of testes or pituitary, but a changeable state. Typical triggers are marked obesity, poorly controlled diabetes, severe co-existing illness, sleep loss and chronic stress. What is special about it: this state can improve when the underlying basis is addressed. Studies suggest that marked weight loss can restart the control. Functional hypogonadism therefore stands in contrast to organic hypogonadism, where a lasting damage is present. This distinction changes what a treatment looks at first.
Is hypogonadism curable or reversible?
That depends on the form. Organic forms such as Klinefelter syndrome or surgical loss of the testes are lasting and usually cannot be undone. Functional forms, by contrast, can improve or regress when the underlying state is changed. Data suggest that marked weight loss can restart hormonal control in men. So the honest answer is: some forms can be reversed, others cannot. That is exactly why careful placement is worthwhile before deciding on a treatment. A blanket statement about curability would not do justice to the complex picture.
How is hypogonadism diagnosed?
Careful diagnostics start with symptoms and examination and then rely on the lab. Testosterone should be measured in the morning and at least twice, because a single value can fluctuate. Alongside it come LH and FSH, to tell primary from secondary hypogonadism, plus free testosterone, prolactin, the binding protein SHBG and further values where needed. Guidelines recommend making the diagnosis only with clearly low values and matching symptoms. In secondary forms, further workup of the pituitary can make sense. Diagnostics therefore place not only a yes or no, but also the where and why.
Can obesity cause hypogonadism?
Yes, obesity is the most common state linked to low testosterone in men and a classic trigger of a functional, secondary hypogonadism. Several mechanisms interlock. Belly fat contains the enzyme aromatase, which converts testosterone into oestrogen. Inflammatory messengers and altered leptin signals from fat tissue can dampen the control in the brain, so less signal reaches the testes. The result is often low testosterone with inappropriately normal LH. The important part: this form is often changeable. Studies suggest that weight loss can restart the control.
When should I see a doctor if I suspect hypogonadism?
You should have a medical workup for lasting fatigue and lack of drive, clearly declining libido, new erection problems, an unfulfilled wish to have children, breast enlargement, and the absence or regression of body hair. Very small testes, a missing sense of smell or an absent puberty also deserve workup, because they can point to particular forms. Behind such symptoms there can be treatable causes, from the pituitary through the thyroid to obesity and medicines. Good diagnostics look at the whole picture and place the finding into a form, rather than judging a single value in isolation.
All 20 topics in the cluster "Hormone Guide (Men)"
This spoke deepens one topic from the pillar. From here you reach every other one.
- Hormones in Men (overview/pillar)
- Testosterone is falling worldwide (every generation less)
- Testosterone deficiency: symptoms in men
- Raising testosterone naturally
- Testosterone test: understanding your values
- TRT: testosterone replacement therapy
- Erectile dysfunction: causes
- Loss of libido in men
- Hypogonadism: forms and causes
- Gynaecomastia: hormonal causes
- Sperm quality and fertility
- Testosterone boosters: what they offer
- Andropause: the male change of life
- Micronutrients for testosterone
- DHT, hair loss and testosterone
- Oestrogen in men and aromatase
- Cortisol, stress, sleep and testosterone
- Obesity, insulin and testosterone
- Xenoestrogens in men
- Sport, strength training and testosterone
- Prolactin and thyroid in men
Connections to other topics
The deeper placement of when a low value is really a deficiency and how it relates to the various forms of hypogonadism.
How chronic stress influences, via the stress axis, the control in the brain that also triggers testosterone production.
Iron deficiency amplifies many symptoms that look like a pure hormone problem, from exhaustion to weakness under load.
Why the thyroid sets the pace of metabolism and a borderline function can influence drive and energy too.
How the higher control from hypothalamus and pituitary also works in women, with parallels to the axis in men.
The gut influences, via the immune system and silent inflammation, how well hormonal control stays in balance.
Sources and further reading
- Wu FCW, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123-135. doi:10.1056/NEJMoa0911101 · PMID: 20554979 [Cohort, Multicenter]
- Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95(4):1810-1818. doi:10.1210/jc.2009-1796 · PMID: 20173018 [Cohort, Multicenter]
- Antonio L, Wu FCW, O'Neill TW, et al. Low Free Testosterone Is Associated with Hypogonadal Signs and Symptoms in Men with Normal Total Testosterone. J Clin Endocrinol Metab. 2016;101(7):2647-2657. doi:10.1210/jc.2015-4106 · PMID: 26909800 [Cohort, Multicenter]
- Boehm U, Bouloux PM, Dattani MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2015;11(9):547-564. doi:10.1038/nrendo.2015.112 · PMID: 26194704 [Consensus Guideline]
- Bonomi M, et al. Klinefelter syndrome: going beyond the diagnosis. Arch Dis Child. 2023;108(3):166-171. doi:10.1136/archdischild-2020-320831 · PMID: 35948402 [Review]
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. doi:10.1210/jc.2018-00229 · PMID: 29562364 [Consensus Guideline]
- Grossmann M. Approach to the Patient: Low Testosterone Concentrations in Men With Obesity. J Clin Endocrinol Metab. 2025. doi:10.1210/clinem/dgaf137 · PMID: 40052430 [Review]
- Dimou NL, et al. Novel perspectives of testosterone therapy in men with functional hypogonadism: traversing the gaps of knowledge. Aging Male. 2024;27(1):2296460. doi:10.1080/13685538.2023.2296460 · PMID: 38149634 [Review]
- Wittert G, Bracken K, Robledo KP, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM). Lancet Diabetes Endocrinol. 2021;9(1):32-45. doi:10.1016/S2213-8587(20)30367-3 · PMID: 33338415 [RCT]
- Yeap BB, Grossmann M, McLachlan RI, et al. Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations. Med J Aust. 2016;205(5):228-231. doi:10.5694/mja16.00448 · PMID: 27581270 [Consensus Guideline]